Hundreds of businesses to attend Vietnam Medipharm Expo 2024

Hundreds of businesses to attend Vietnam Medipharm Expo 2024

Vietnam Medipharm Expo 2024 will take place in Hanoi from December 5-7.
Enabling environment expected for international pharma firms

Enabling environment expected for international pharma firms

The draft amendment to the Law on Pharmacy plays a crucial role in promoting innovation and modernisation of the Vietnamese healthcare sector, especially in the context of international integration and the growing demand for improved healthcare quality.
Incentives ahead for pharma industry

Incentives ahead for pharma industry

Vietnam’s pharmaceutical industry has reached level three under the World Health Organisation’s classification, as the country can now produce some basic raw materials. However, it has yet to fully develop raw material production, as it cannot compete with imported materials.
Competition within ASEAN for pharma investment

Competition within ASEAN for pharma investment

With an ageing population, rising disease burden, and advancements in healthcare science, the global pharmaceutical market has seen significant growth in recent years. In 2023, the total market was estimated at $1.6 trillion, an increase in over $100 billion compared to 2022. As one of the largest and fastest-growing industries, the sector drives healthcare innovation globally.
AstraZeneca reinforces commitment to healthcare

AstraZeneca reinforces commitment to healthcare

Pharma giant AstraZeneca is solidifying its position as a pioneer in healthcare innovation in Vietnam.
Pharma to experience robust growth

Pharma to experience robust growth

Vietnam healthcare market size is estimated to reach $23.7 billion and grow at an average rate of 7.5 per cent annually from 2023 to 2028. Healthcare expenditure per capita is also projected to increase from $237 to $328 in that time.
Pharma businesses lean towards to open innovation

Pharma businesses lean towards to open innovation

The pharmaceutical business community expects that the draft amendments to the Law on Pharmacy 2016 will be adopted by the National Assembly at the October 2024 session. The revised draft law has groundbreaking contents that create new advantages for businesses in the industry, including those of Vietnam Pharmaceutical Companies Association.
Big Pharma push back on first Medicare drug price cuts

Big Pharma push back on first Medicare drug price cuts

Major pharmaceutical companies lashed out following a landmark deal unveiled Thursday to cut the costs of 10 key medicines, with some saying the price-setting process was not transparent.
MSD Vietnam’s empowering workplace

MSD Vietnam’s empowering workplace

Pharma company MSD Vietnam has been recognised at the HR Asia Awards 2024 for its exceptional human resource policies.
Vietnam welcomes major Indian pharmaceutical investments

Vietnam welcomes major Indian pharmaceutical investments

Leading Indian pharmaceutical corporations have proposed significant investment in Vietnam.
Overhaul anticipated for transfer of pharma tech

Overhaul anticipated for transfer of pharma tech

Domestic and multinational corporations are expected to enjoy specific incentive policies for their tech transfer plans in Vietnam’s pharmaceutical industry.
Bayer unveils medical breakthroughs

Bayer unveils medical breakthroughs

Bayer is set to embark on its next phase of growth with a new wave of medical breakthroughs.
Global pharma expects bumper year

Global pharma expects bumper year

Increasing footprints in Vietnam in 2023, multinational corporations continue to eye stronger local partnerships to bring more new innovative medicines and vaccines to the local market in 2024 and beyond.
Legal landscape adjusted for global pharma groups

Legal landscape adjusted for global pharma groups

Multinational corporations operating in Vietnam are expected to benefit from new legal changes in the months to come, after years of delay.
Local pharma giants reaping rewards with new strategies

Local pharma giants reaping rewards with new strategies

While the shift to the hospital channel brought fruitful results for major pharma players in Vietnam in 2023, competition is forecast to heat up in the future.
|< < 1 2 3 4 > >|